白云山:复方板蓝根颗粒的销售预计不会对公司的经营业绩构成重大影响

华尔街见闻 · 2020-10-18
白云山发布澄清公告称,有关媒体报道所涉及的相关结论只是针对公司合营企业白云山和黄公司复方板蓝根颗粒开展的抗新型冠状病毒体外筛选的实验结果,后续还需对该产品开展进一步相关工作,相关工作尚存在一定的不确定性。复方板蓝根颗粒的销售预计不会对本公司的经营业绩构成重大影响。

Long Bridge Securities Ltd is a New Zealand registered Financial Service Provider (FSP number: FSP600050), and is a member of the Financial Dispute Resolution Scheme, a New Zealand independent dispute resolution service provider.

All data and contents of the Long Bridge website (longbridge.global) are for investors' reference only. Before conducting investment activities, investors should fully understand the relevant products, clearly know their potential risks, and make rational decisions based on their own risk tolerance; and investors should be aware that all investment activities involve risks and investment activities may not be suitable for every investor.

Customer Service (Only for general enquiries):400-071-2688

0800 33 9033 / (09) 533 9033(New Zealand)

Support Email: service@longbridge.global
简体中文